ImmuneWatch
ActiveSummary
ImmuneWatch has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€30,203) and a net result of €8,523. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 605 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Directors
Directors
No directors read yet: 0 of 5 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.